|
1
|
Favoriti P, Carbone G, Greco M, Pirozzi F,
Pirozzi RE and Corcione F: Worldwide burden of colorectal cancer: A
review. Updates Surg. 68:7–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miller KD, Nogueira L, Mariotto AB,
Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL and Siegel
RL: Cancer treatment and survivorship statistics, 2019. CA Cancer J
Clin. 69:363–385. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brudvik KW, Kopetz SE, Li L, Conrad C,
Aloia TA and Vauthey JN: Meta-analysis of KRAS mutations and
survival after resection of colorectal liver metastases. Br J Surg.
102:1175–1183. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zampino MG, Magni E, Ravenda PS, Cella CA,
Bonomo G, Della Vigna P, Galdy S, Spada F, Varano GM, Mauri G, et
al: Treatments for colorectal liver metastases: A new focus on a
familiar concept. Crit Rev Oncol Hematol. 108:154–163. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Elble RC and Pauli BU: Tumor suppression
by a proapoptotic calcium-activated chloride channel in
mammaryepithelium. J Biol Chem. 276:40510–40517. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Patel AC, Brett TJ and Holtzman MJ: The
role of CLCA proteins in inflammatory airway disease. Annu Rev
Physiol. 71:425–449. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Piirsoo M, Meijer D and Timmusk T:
Expression analysis of the CLCA gene family in mouse and human with
emphasis on the nervous system. BMC Dev Biol. 9:102009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang B, Cao L, Liu B, McCaig CD and Pu J:
The transition from proliferation to differentiation in colorectal
cancer is regulated by the calcium activated chloride channel A1.
PLoS One. 8:e608612013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sasaki Y, Koyama R, Maruyama R, Hirano T,
Tamura M, Sugisaka J, Suzuki H, Idogawa M, Shinomura Y and Tokino
T: CLCA2, a target of the p53 family, negatively regulates cancer
cell migration and invasion. Cancer Biol Ther. 13:1512–1521. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qiang YY, Li CZ, Sun R, Zheng LS, Peng LX,
Yang JP, Meng DF, Lang YH, Mei Y, Xie P, et al: Along with its
favorable prognostic role, CLCA2 inhibits growth and metastasis of
nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.
J Exp Clin Cancer Res. 37:342018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Walia V, Yu Y, Cao D, Sun M, McLean JR,
Hollier BG, Cheng J, Mani SA, Rao K, Premkumar L and Elble RC: Loss
of breast epithelial marker hCLCA2 promotes
epithelial-to-mesenchymal transition and indicates higher risk of
metastasis. Oncogene. 31:2237–2246. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Z, Chen M, Xie LK, Liu T, Zou ZW, Li
Y, Chen P, Peng X, Ma C, Zhang WJ and Li PD: CLCA4 inhibits cell
proliferation and invasion of hepatocellular carcinoma by
suppressing epithelial-mesenchymal transition via PI3K/AKT
signaling. Aging (Albany NY). 10:2570–2584. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu Y, Walia V and Elble RC: Loss of CLCA4
promotes epithelial-to-mesenchymal transition in breast cancer
cells. PLoS One. 8:e839432013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hou T, Zhou L, Wang L, Kazobinka G, Zhang
X and Chen Z: CLCA4 inhibits bladder cancer cell proliferation,
migration, and invasion by suppressing the PI3K/AKT pathway.
Oncotarget. 8:93001–93013. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Loewen ME and Forsyth GW: Structure and
function of CLCA proteins. Physiol Rev. 85:1061–1092. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vogelstein B, Papadopoulos N, Velculescu
VE, Zhou S, Diaz LA Jr and Kinzler KW: Cancer genome landscapes.
Science. 339:1546–1558. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Del Rio M, Molina F, Bascoul-Mollevi C,
Copois V, Bibeau F, Chalbos P, Bareil C, Kramar A, Salvetat N,
Fraslon C, et al: Gene expression signature in advanced colorectal
cancer patients select drugs and response for the use of
leucovorin, fluorouracil, and irinotecan. J Clin Oncol. 25:773–780.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cancer Genome Atlas Network: Comprehensive
molecular characterization of human colon and rectal cancer.
Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Uhlen M, Oksvold P, Fagerberg L, Lundberg
E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S,
et al: Towards a knowledge-based human protein atlas. Nat
Biotechnol. 28:1248–1250. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kato T, Hayama S, Yamabuki T, Ishikawa N,
Miyamoto M, Ito T, Tsuchiya E, Kondo S, Nakamura Y and Daigo Y:
Increased expression of insulin-like growth factor-II messenger RNA
binding protein 1 is associated with tumor progression in patients
with lung cancer. Clin Cancer Res. 13:434–442. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hong Y, Downey T, Eu KW, Koh PK and Cheah
PY: A ‘metastasis-prone’ signature for early-stage mismatch-repair
proficient sporadic colorectal cancer patients and its implications
for possible therapeutics. Clin Exp Metastasis. 27:83–90. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kaiser S, Park YK, Franklin JL, Halberg
RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, et
al: Transcriptional recapitulation and subversion of embryonic
colon development by mouse colon tumor models and human colon
cancer. Genome Biol. 8:R1312007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Skrzypczak M, Goryca K, Rubel T, Paziewska
A, Mikula M, Jarosz D, Pachlewski J, Oledzki J and Ostrowsk J:
Modeling oncogenic signaling in colon tumors by multidirectional
analyses of microarray data directed for maximization of analytical
reliability. PLoS One. 5:e130912010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sabates-Bellver J, Van der Flier LG, de
Palo M, Cattaneo E, Maake C, Rehrauer H, Laczko E, Kurowski MA,
Bujnicki JM, Menigatti M, et al: Transcriptome profile of human
colorectal adenomas. Mol Cancer Res. 5:1263–1275. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gaedcke J, Grade M, Jung K, Camps J, Jo P,
Emons G, Gehoff A, Sax U, Schirmer M, Becker H, et al: Mutated KRAS
results in overexpression of DUSP4, a MAP-kinase phosphatase, and
SMYD3, a histone methyltransferase, in rectal carcinomas. Genes
Chromosomes Cancer. 49:1024–1034. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bundela S, Sharma A and Bisen PS:
Potential therapeutic targets for oral cancer: ADM, TP53, EGFR,
LYN, CTLA4, SKIL, CTGF, CD70. PLoS One. 9:e1026102014. View Article : Google Scholar : PubMed/NCBI
|
